NEW YORK, April 17, 2024 – Isaac Health, a leading national provider of brain health and dementia care, is thrilled to expand their existing relationship with New York-headquartered CaringKind to offer individuals and families affected by dementia new support provided through the Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) …
NEW YORK, New York, April 9, 2024 – Isaac Health, a leading national provider of brain health and dementia care, has been accepted in the established and new model tracks of the Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) Model. The GUIDE Model focuses on enhancing care for individuals …
Isaac Health is an accepted participant in CMS GUIDE Model Program Read More »
Isaac Health has recently become a participating site in the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET). Sponsored by the Alzheimer’s Association and managed by the American College of Radiology, ALZ-NET is a collaborative effort to improve brain health outcomes across the nation and drive innovation in the ways we care for and treat Alzheimer’s disease and other dementias.
Introduction: The recent full approval of Lecanemab (Leqembi) by the FDA has ushered in a new era in the treatment of Alzheimer’s disease. As the first disease-modifying treatment to receive such approval, Leqembi offers hope to patients with early-stage Alzheimer’s. However, its adoption poses cost implications for payers and risk-bearing health systems. In a newly …
Introduction: On July 6, 2023, the FDA granted full approval to Lecanemab (Leqembi), marking a significant milestone as the first disease-modifying treatment for Alzheimer’s disease to receive such approval. This white paper aims to inform health insurance employees about the implications of Leqembi’s approval and offer insights into coverage considerations and potential cost implications. Coverage …
Leqembi – Implications for Health Insurance Payers: A Comprehensive Analysis Read More »
About Leqembi Leqembi is the first of (very likely) many forthcoming drugs that will be revolutionizing the landscape of early stage Alzheimer’s disease. With its traditional (full) FDA approval come new questions from our patients and community surrounding its availability, manufacturer, purchasing options, working mechanism, insurance coverage, and comparisons with other medications. Our doctors here …
Rosalynn Carter, the former First Lady and a prominent advocate for mental health care, has been diagnosed with dementia, as announced by the Carter Center and reported by the New York Times. This revelation follows her husband, former President Jimmy Carter’s decision to enter hospice care. Despite the diagnosis, Mrs. Carter, at 95 years old, …
Insights on former First Lady, Rosalynn Carter’s Diagnosis Read More »
Last night at the Clinical Trials in Alzheimer’s Disease conference, Eisai finally shared the results of its highly anticipated Phase 3 clinical trial, CLARITY AD.
FINGER study on Alzheimer prevention suggesting a multidomain intervention is effective in preventing a significant proportion of Alzheimer cases: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60461-5/fulltext Global study based on the FINGER study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222931/ CAIDE study on addressable Alzheimer Risk Factors: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(06)70537-3/fulltext Helpful overview of all risk factors and prevention recommendations: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2244657/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514088/ The approach of the Weill Cornel Alzheimer prevention …
Select evidence for the prevention of Alzheimer’s Disease Read More »
Alzheimers.gov has put together a series of websites to help caregivers navigate the journey of caring for the loved ones: National Institute on Aging (NIA)Advance Care Planning Learn about financial and health care planning, including advance directives. National Institute on Aging (NIA)Alzheimer’s Caregiving Learn how to respond to changes in communication and behavior, provide everyday …
